Followers | 259 |
Posts | 3732 |
Boards Moderated | 0 |
Alias Born | 04/26/2013 |
Wednesday, November 13, 2013 10:49:33 AM
The bull case on MJNA is that prices will fall (scale, cheaper hemp when domestic production is allowed) and that demand will rise for CBD-infused products. The CBD dosing for epilepsy is an astounding 400mg. I believe that's one-time daily. There was an article last night and another today that shows me that while CBD awareness is increasing, MJNA isn't always winning the p.r. battle. See the falsehoods in these two articles for yourself:
http://www.sltrib.com/sltrib/news/57118270-78/utah-marijuana-hemp-colorado.html.csp
http://www.digitaljournal.com/pr/1583010
MJNA has a lot of baggage that I hope that they can clean up soon. I am more focused these days on trying to assess what investors will do if the company announces that its products are being stocked by Whole Foods or the like. In my opinion, that day is coming.
If you don't like my posts, don't read them. If you think only those who agree with you should post, then start your own message board. My conclusions are my opinion only, based on what I believe to be true. I have no crystal ball.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM